/newsroom/ en /newsroom/news/list/2024/08/28/research-centre-funded-for-global-control-of-two-serious-infections-in-young ×îÐÂÌÇÐÄVlog of Adelaide researchers have received $3 million for a new research centre set to determine the most effective immunisation program using one vaccine to protect against both meningococcal disease and gonorrhoea. August 30 2024 Lara Pacillo /newsroom/news/list/2024/08/28/research-centre-funded-for-global-control-of-two-serious-infections-in-young /newsroom/news/list/2021/07/22/life-saving-meningococcal-b-vaccination-program-continues-indefinitely South ×îÐÂÌÇÐÄVlog's world-leading Meningococcal B Immunisation Program will continue indefinitely after proving it’s been incredibly effective at preventing the illness in high-risk age groups thanks to research at the ×îÐÂÌÇÐÄVlog of Adelaide. July 22 2021 Elisa Black /newsroom/news/list/2021/07/22/life-saving-meningococcal-b-vaccination-program-continues-indefinitely /newsroom/news/list/2020/04/22/fears-childrens-immunisation-rates-will-drop There are fears parents will skip vital vaccinations for their children and that there may be disease outbreaks, because parents are concerned about taking their children to their GP during the COVID-19 pandemic. April 22 2020 Elisa Black /newsroom/news/list/2020/04/22/fears-childrens-immunisation-rates-will-drop /newsroom/news/list/2020/01/23/study-results-will-inform-immunisation-programs-globally The results of the B Part of It study – the largest meningococcal B herd immunity study ever conducted – are published today in the New England Journal of Medicine. January 23 2020 David Ellis /newsroom/news/list/2020/01/23/study-results-will-inform-immunisation-programs-globally